Jiango Pharma Is in the Bargain Basement
China OTC Player submits:
By Platinum Tiger
Jiangbo Pharmaceuticals (JGBO.OB), a stock I recommended here about two months ago, committed an investor relations gaffe in late February that has driven its stock price down to its lowest and most attractive levels in about a year. What was a blow to the momentum investors who recently bailed out is a positive boon to those seeking bargains in the bullish Chinese small cap market.
Investing, Long Term Investment, stock market | admin March 7, 2010
RSS feed for comments on this post.
